192 related articles for article (PubMed ID: 3886765)
1. The copper-controlled diet: current aspects of dietary copper restriction in management of copper metabolism disorders.
Smithgall JM
J Am Diet Assoc; 1985 May; 85(5):609-10. PubMed ID: 3886765
[No Abstract] [Full Text] [Related]
2. A copper for your thoughts.
Coates RA
J Insur Med; 2012; 43(2):112-5. PubMed ID: 22876415
[No Abstract] [Full Text] [Related]
3. [Metabolism of copper and its disorders].
Hauftová D
Cas Lek Cesk; 1975 Mar; 114(10-11):341-5. PubMed ID: 1139583
[No Abstract] [Full Text] [Related]
4. [Hepatolenticular degeneration: biochemical and therapeutic considerations].
Clin Ter; 1976 Mar; 76(6):567-76. PubMed ID: 828082
[No Abstract] [Full Text] [Related]
5. [From gene to disease; Wilson disease: copper storage due to mutations in ATP7B].
Hoogenraad TU
Ned Tijdschr Geneeskd; 2003 Jul; 147(28):1386-7. PubMed ID: 12892020
[No Abstract] [Full Text] [Related]
6. Zinc treatment for symptomatic Wilson disease: moving forward by looking back.
Schilsky M
Hepatology; 2009 Nov; 50(5):1341-3. PubMed ID: 19877301
[No Abstract] [Full Text] [Related]
7. Treatment of Wilson's disease (hepatolenticular degeneration) with penicillamine and low-copper diet.
Goldstein NP; Tauxe WN; McCall JT; Gross JB; Randall RV
Trans Am Neurol Assoc; 1969; 94():34-7. PubMed ID: 5374484
[No Abstract] [Full Text] [Related]
8. Wilson's disease: clinical management and therapy.
Brewer GJ; Askari FK
J Hepatol; 2005; 42 Suppl(1):S13-21. PubMed ID: 15777568
[No Abstract] [Full Text] [Related]
9. Copper metabolism in primary biliary cirrhosis.
Vierling JM
Semin Liver Dis; 1981 Nov; 1(4):293-308. PubMed ID: 7051310
[No Abstract] [Full Text] [Related]
10. Copper metabolism in patients with liver disease.
Nutr Rev; 1977 Jun; 35(6):136-8. PubMed ID: 327353
[No Abstract] [Full Text] [Related]
11. [Clinical character and therapeutic effect of late-onset Wilson disease].
Zhang Y; Yang X; Tang X; Luo H; Lei J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Jan; 34(1):40-4. PubMed ID: 19197125
[TBL] [Abstract][Full Text] [Related]
12. [Management of hepatocerebral degeneration].
Fouquet H; Broser F
Med Klin; 1977 Dec; 72(50):2174-7. PubMed ID: 593201
[No Abstract] [Full Text] [Related]
13. [Wilson's disease (hepatolenticular degeneration)].
Bickel H
Internist (Berl); 1966 Jan; 7(1):27-33 passim. PubMed ID: 4964272
[No Abstract] [Full Text] [Related]
14. Effect of D-penicillamine on liver fibrosis and inflammation in Wilson disease.
Kazemi K; Geramizadeh B; Nikeghbalian S; Salahi H; Bahador A; Reza Nejatollahi SM; Dehghani SM; Dehghani M; Kakaei F; Malek-Hosseini SA
Exp Clin Transplant; 2008 Dec; 6(4):261-3. PubMed ID: 19338486
[TBL] [Abstract][Full Text] [Related]
15. Penicillamine-induced normalization of clinical signs, and liver morphology and histochemistry in a case of Wilson's disease.
Falkmer S; Samuelson G; Sjölin S
Pediatrics; 1970 Feb; 45(2):260-8. PubMed ID: 5413388
[No Abstract] [Full Text] [Related]
16. Metabolic studies in Wilson's disease. Evaluation of efficacy of chelation therapy in respect to copper balance.
Strickland GT; Blackwell RQ; Watten RH
Am J Med; 1971 Jul; 51(1):31-40. PubMed ID: 5570318
[No Abstract] [Full Text] [Related]
17. Copper chelation in patients with Wilson's disease. A comparison of penicillamine and triethylene tetramine dihydrochloride.
Walshe JM
Q J Med; 1973 Jul; 42(167):441-52. PubMed ID: 4728043
[No Abstract] [Full Text] [Related]
18. [Wilson's disease and secondary copper hemochromatoses in hematological practice].
Vorob'ev AI; Lukina EA; Sysoeva EP; Levina AA; Solov'eva TI
Ter Arkh; 2004; 76(7):55-9. PubMed ID: 15379129
[TBL] [Abstract][Full Text] [Related]
19. The story of penicillamine: a difficult birth.
Walshe JM
Mov Disord; 2003 Aug; 18(8):853-9. PubMed ID: 12889074
[No Abstract] [Full Text] [Related]
20. [Therapy of Wilson disease].
Smolarek C; Stremmel W
Z Gastroenterol; 1999 Apr; 37(4):293-300. PubMed ID: 10378366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
